Resources

In this blog, Elisa Petris, Partner at Syncona Investment Management Limited, and Emma Johnson, Senior Investment Manager – Life Sciences at the British Business Bank, write in their capacity as Co-founders of Invest in Equity. They share why they launched the initiative, the urgency of improving gender diversity in life science investment, and how a more inclusive ecosystem can drive stronger returns and better outcomes for patients.

BIA member Charm Therapeutics, co-founded by Nobel laureate David Baker, has raised an $80 million Series B to move its AI-designed cancer drug into the clinic early next year.

The fourth edition of the Tech Kickstarter Competition is now open for applications. If you are a seed or early-stage company working on a breakthrough product in life sciences, green tech, or tech/AI, this is your chance to accelerate your tech development.

Coulter Partners successfully completed a search assignment for AstriVax Therapeutics NV and is pleased to announce the placement of Dieter Weinand as Chair of its Board of Directors.

The Cell and Gene Therapy Catapult (CGT Catapult) are absolutely delighted to share that it’s Skills Team has been recognised as one of the 57 exceptional training programmes to receive the prestigious Princess Royal Training Award this year for creating a future-ready workforce for advanced therapies!

Shaun Grady is becoming BIA chair, effective from January 2026, in another week of innovation for our sector.

Shaun Grady will be the new Chair of BIA, effective from January 2026. He succeeds Dr Daniel Mahony, who has served as BIA Chair since January 2022 and has played a pivotal role in steering the association.

In our latest blog, Isabel Vincent, Market Development Manager at Firefinch Software, shares how the team is driving innovation with custom software, harnessing AI and exploring cutting-edge imaging technologies, helping to shape the future of biotech and MedTech.

Discovery Park today announced the arrival of two pioneering biotech companies to its innovation campus.

Myricx Bio (‘Myricx’), a UK-based biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), is pleased to announce the appointment of Penny Fatato in the newly created position of Global Head of Clinical Operations, based in Philadelphia, Pennsylvania, USA.

In this blog, Charlotte shares how her experience as a mentee on the BIA’s Women in Biotech mentoring programme helped her build confidence, embrace her leadership style, and navigate the challenges of a growing career in biotech. 

Discovery Park has partnered with global proptech leader Equiem to launch Discover More — a purpose-built app that redefines how people work, connect, and collaborate across the 220-acre site. Home to over 180 pioneering companies working across science and technology, the new app is designed to make every tenant’s day-to-day experience more efficient and better connected, supporting an active tenant community and innovation ecosystem.

Call for BIA Board candidates. We are delighted to invite nominations from individuals interested in joining the BIA Board.

Brainomix, a global leader in AI-powered imaging solutions in stroke and lung fibrosis, has announced the appointment of Anna Griffin as Chief Financial Officer, filling a key leadership role within the company following its recent £14 million Series C funding round.

The BioIndustry Association (BIA) is now inviting applications for its 2026 Charity Partnership.

Members of the Industry Skills Accelerator (ISA) have celebrated a successful year of strengthening the UK’s medicines manufacturing workforce.

Rosalind brings extensive leadership experience across the health and life sciences sector. She has led the Government’s Office for Life Sciences for the last four years, bringing together the Government, the NHS, academia and industry to drive improved patient outcomes and economic growth through life sciences.

Members of the Industry Skills Accelerator (ISA) have celebrated a successful year of strengthening the UK’s medicines manufacturing workforce.

CGT Catapult, an independent technology and innovation organisation specialising in the advancement of the cell and gene therapy industry, has appointed Dr Jim Faulkner as its new Chairman, effective from 29th July 2025.

In my final summer update as BIA CEO, I reflect on 12 amazing years and look ahead to my new role as Executive Chair of the Office for Life Sciences. This week we’ve also published our latest finance report, and we’re hiring - so if you’re looking for your next challenge, now’s the time to join Team BIA.